NCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy treatment 3 not_yet_recruiting NCT04640649
Prediction of Progression of Age-Related Macular Degeneration No drug interventions diagnostic Not Available unknown_status NCT04847635
Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration No drug interventions treatment Not Available recruiting NCT04084587
Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration No drug interventions treatment Not Available completed NCT05418231
Observation of the Natural Course of Age-related Macular Degeneration No drug interventions Not Available Not Available not_yet_recruiting NCT03921931
Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study No drug interventions basic_science Not Available recruiting NCT02684578
Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD treatment 2 completed NCT04469140
Non Exudative AMD Imaged With SS-OCT- Extension No drug interventions Not Available Not Available recruiting NCT03688243
Non Exudative AMD Imaged With SS-OCT No drug interventions Not Available Not Available unknown_status NCT02699216
BioCurrent Electrical Stimulation for the Treatment of Dry ARMD No drug interventions treatment Not Available withdrawn NCT02590692
Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD No drug interventions other 1 / 2 unknown_status NCT02024269
Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration No drug interventions treatment Not Available withdrawn NCT01342926
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration No drug interventions treatment 2 completed NCT02033668
Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers No drug interventions treatment 1 completed NCT03845582
Phase 3 Study of ALK-001 in Geographic Atrophy treatment 3 active_not_recruiting NCT05811351
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) treatment 2 recruiting NCT06635148
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) No drug interventions treatment 2 recruiting NCT05019521
A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration treatment 2 active_not_recruiting NCT05626114
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration No drug interventions treatment 2 recruiting NCT06018558
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy No drug interventions treatment 1 / 2 recruiting NCT05961332
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy No drug interventions other Not Available recruiting NCT06394232
Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. treatment 1 / 2 recruiting NCT02332343
Sparing of the Fovea in Geographic Atrophy Progression No drug interventions Not Available Not Available completed NCT04339764
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration No drug interventions treatment 1 / 2 recruiting NCT01666821
A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population No drug interventions Not Available Not Available completed NCT06161584
A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration Not Available Not Available recruiting NCT02247479
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration treatment 3 terminated NCT06164587
Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy No drug interventions treatment 1 recruiting NCT04676854
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD No drug interventions treatment Not Available active_not_recruiting NCT04014777
Study of NGM621 in Participants With Geographic Atrophy No drug interventions treatment 1 completed NCT01675947
Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy treatment 2 terminated NCT02659098
A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy treatment 2 completed NCT05536297
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy treatment 3 active_not_recruiting NCT00973011
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy treatment 1 completed NCT03846193
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD No drug interventions treatment 1 / 2 terminated NCT01866371
High Resolution Retinal Imaging No drug interventions Not Available Not Available recruiting NCT04358471
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA) No drug interventions treatment 2 withdrawn NCT06499571
Geographic Atrophy Long-Terms Outcomes Study No drug interventions Not Available Not Available completed NCT02800356
Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD No drug interventions treatment Not Available completed NCT02137915
Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration No drug interventions Not Available Not Available terminated NCT02895815
Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) treatment 2 withdrawn NCT02503332
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy treatment 2 completed NCT03525600
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration treatment 3 completed NCT02288559
A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy treatment 2 completed NCT00429936
Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration treatment 2 completed NCT02372916
Geographic Atrophy and Intravitreal Ranibizumab Injections Not Available Not Available unknown_status NCT06510816
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA) No drug interventions treatment 3 recruiting NCT02686658
Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration treatment 2 / 3 completed NCT03815825
GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) No drug interventions treatment 2 completed NCT04607148
A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration treatment 2 terminated NCT01445548
Sirolimus for Advanced Age-Related Macular Degeneration treatment 1 / 2 completed NCT06351657
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression No drug interventions Not Available Not Available not_yet_recruiting NCT01802866
Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride treatment 2 / 3 completed NCT05391074
Oral Postbiotics in Patients With Macular Atrophy No drug interventions treatment Not Available unknown_status NCT02247531
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration treatment 3 terminated NCT02130531
Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration treatment 1 completed NCT06557460
A PHASE IIB, RANDOMIZED, ASSESSOR-MASKED, MULTICENTER CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SUBRETINAL IMPLANTATION OF THE CPCB-RPE1 IMPLANT IN SUBJECTS WITH ADVANCED, DRY AMD (GEOGRAPHIC ATROPHY) No drug interventions treatment 2 not_yet_recruiting NCT04744662
ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration treatment 1 completed NCT01782989
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) treatment 2 / 3 completed NCT05963646
Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study No drug interventions Not Available Not Available completed NCT00599846
The Natural History of Geographic Atrophy Progression (GAP) Study No drug interventions Not Available Not Available terminated NCT01694095
Evolution and Risk Factors Associated With Geographic Atrophy Progression No drug interventions Not Available Not Available completed NCT04465955
A Study of NGM621 in Participants With Geographic Atrophy No drug interventions treatment 2 completed NCT01002950
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy treatment 2 completed NCT01692938
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO No drug interventions Not Available Not Available completed NCT01799564
Micropulse Laser for Geographic Atrophy No drug interventions treatment Not Available completed NCT03295877
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) treatment 1 completed NCT00890097
Geographic Atrophy Treatment Evaluation No drug interventions treatment 3 terminated NCT04656561
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy No drug interventions treatment 2 completed NCT05949593
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy treatment 3 recruiting NCT00306488
OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration treatment 2 completed NCT03972709
A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) treatment 2 terminated NCT06006585
A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy No drug interventions treatment 1 completed NCT02087085
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration treatment 2 terminated NCT01229215
A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy treatment 2 completed NCT03777332
Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy treatment 1 completed NCT05438732
Multicenter Clinical Study of the SING-IMT in Patients With Late-stage AMD No drug interventions other Not Available recruiting NCT01527500
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD) treatment 2 completed NCT05891275
Patients With Geographic Atrophy and Their Patient Journey in the United States (US) No drug interventions Not Available Not Available completed NCT01093170
A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy No drug interventions treatment 1 withdrawn NCT02515942
CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA) treatment 2 completed NCT03525613
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration treatment 3 completed NCT04739319
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression No drug interventions Not Available Not Available recruiting NCT02745119
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) treatment 3 terminated NCT06381596
Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration No drug interventions other Not Available recruiting NCT05797896
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study No drug interventions Not Available Not Available recruiting NCT02479386
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration No drug interventions Not Available Not Available terminated NCT04643886
A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration No drug interventions treatment 2 terminated NCT04615325
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration No drug interventions treatment 1 completed NCT04246866
First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration No drug interventions treatment 1 completed NCT04435366
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) treatment 3 completed NCT01602120
An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy treatment 2 terminated NCT03894020
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) No drug interventions Not Available Not Available active_not_recruiting NCT05941273
A Study of the SING IMT in an Israeli Cohort No drug interventions treatment Not Available not_yet_recruiting NCT01272076
Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE) No drug interventions Not Available Not Available completed NCT05380492
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration No drug interventions treatment 1 / 2 active_not_recruiting NCT03446144
Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) No drug interventions treatment 2 withdrawn NCT02399072
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration No drug interventions Not Available Not Available terminated NCT01603043
A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD) No drug interventions treatment 2 terminated